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ABSTRACT
Diverse tools are available for performing genetic
modifications of microorganisms. However, new
methods still need to be developed for performing
precise genomic engineering without introducing
any undesirable side-alteration. Indeed for function-
al analyses of genomic elements, as well as for
some industrial applications, only the desired
mutation should be introduced at the locus con-
sidered. This article describes a new approach ful-
filling these requirements, based on the use of
selection systems consisting in truncated genes
encoding dominant-negative transcription factors.
We have demonstrated dominant-negative effects
mediated by truncated Gal4p and Arg81p proteins
in Saccharomyces cerevisiae, interfering with gal-
actose and arginine metabolic pathways, respect-
ively. These genes can be used as positive and
negative markers, since they provoke both growth
inhibition on substrates and resistance to specific
drugs. These selection markers have been success-
fully used for precisely deleting HO and URA3 in wild
yeasts. This genetic engineering approach could be
extended to other microorganisms.
INTRODUCTION
In the past decades, various systems have been established
for genetic engineering of prototroph microorganisms,
including wild yeasts. Powerful tools have been developed,
in ﬁrst instance using Saccharomyces cerevisiae, in the
context of the collaborative genome sequencing and func-
tional analysis projects (1–3). Classically, the ﬁrst step
consists in selecting linear vector integration by homolo-
gous recombination at the target locus. Then, internal
vector elements are removed by homologous recombin-
ation between appropriately designed, directly repeated,
ﬂanking sequences (4). To perform genomic modiﬁcations
in prototroph yeasts dominant selective markers leading
to drug resistance are available, such as neo, which confers
resistance to G418 (5), but convenient negative selection
systems for subsequent elimination of vector sequences
remained to be developed. Indeed, excision of the select-
able marker spontaneously occurs by recombination
between short directly repeated ﬂanking sequences, but
its frequency is very low (6). Therefore, genes encoding
speciﬁc recombinases have been additionally used,
together with speciﬁc pairs of target sequences included
in the integrative vectors, which allowed increasing the
homologous recombination frequency (7,8). Then, only a
short piece of foreign DNA including the recombinase
recognition sequence remains at the modiﬁed locus.
However, for genetic engineering of various functional
elements, but also for several applications involving indus-
trial strains, vector excision leading to the elimination of
all foreign DNA sequences is desired. Such requirements
exclude the use of systems involving speciﬁc recombinases.
Some years ago, Akada et al. (9) and Olesen et al. (10)
developed a counter-selection method for vector recycling
in S. cerevisiae based on conditioned over-expression of
two particular genes (GIN11 and PKA3) encoding
proteins which cause lethality when overproduced (9,10).
These systems, combined with a positive marker, were
successfully used in some industrial strains (9–11).
However, they need to be adapted according to the
behavior of a conditional promoter but also to the
potency of the particular growth-inhibitory protein in
the yeast host strain of interest (10). Considering these
constraints and the diverse metabolic features of target
hosts, it is obvious that new tools still need to be
developed.
The approach described here is based on the use of ex-
pression cassettes encoding dominant-negative truncated
transcription factors designed for interfering with speciﬁc
regulatory pathways. Such defective transcription factors
have been extensively used for fundamental research in
higher eukaryotic cells, due to the difﬁculties of reverse
genetics, or in view of therapeutic applications (12).
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isms, this tool has only been marginally used, for studying
metabolic functions (13–16). For genetic engineering of
prototroph microorganisms, dominant-negative transcrip-
tion factors would provide ideal tools. Indeed, this
approach should allow the design of both positive and
negative selection systems that are very efﬁcient and
should be appropriate for performing any precise
genomic modiﬁcation. Using such strategy, we performed
several precise genetic modiﬁcations in two wild strains
isolated from banana leaves in Thailand (17).
Two systems were established, respectively interfering
with the catabolism of galactose and with the metabolism
of arginine. In the absence of galactose, the transcriptional
activator Gal4p is bound to speciﬁc sites (UAS) upstream
the structural GAL genes, but is unable to activate their
transcription, since the activation domain is masked by
Gal80p (18). In the presence of galactose, the Gal4p acti-
vation domain is liberated. Consequently, expression of
GAL1, GAL2, GAL7 and GAL10 is induced (19). To be
efﬁcient, the induction requires the relief of carbon catab-
olite repression.
A truncated transcription factor, Gal4p (aa 1–147) is
known to be localized in the nucleus and to bind to the
UAS upstream the GAL genes, while being unable to
activate their transcription in the presence of galactose
(20–23). Overproduction of Gal4p was expected to
lead to competition with the endogenous Gal4p
(which is produced at very low level) for binding to
the DNA target sites, which should give rise to inhibition
of induction in the presence of galactose, and to inhibition
of growth on galactose as carbon source. We also expected
that, when grown on a medium containing appropriate
amounts of glucose and galactose, a yeast producing
Gal4p should be less sensitive to 2-deoxy-galactose
(2DG), a pro-drug whose toxicity was previously
demonstrated to be increased in strains constitutively
producing the enzymes of the pathway (24). Therefore, a
gene encoding Gal4p was placed under the control of a
strong constitutive promoter, in view of designing both
positive and negative selection systems.
The arginine biosynthetic pathway consists of ﬁve
enzymes allowing conversion of glutamate to ornithine,
which is then converted in arginine in three steps [orni-
thine carbamoyltransferase (ARG3), argininosuccinate
synthetase (ARG1) and lyase (ARG4)] (25). Arginine can
be degraded by arginase (CAR1), giving rise to urea and
ornithine which is modiﬁed by a transaminase (CAR2)
into glutamate semialdehyde, giving rise to glutamate
and ammonium after several steps. Regulation of
arginine anabolic and catabolic pathways is dependent
on the availability of arginine or ornithine as nitrogen
source. Several regulatory systems are involved, including
a speciﬁc transcriptional control which regulates the
production of both anabolic and catabolic enzymes and
involves the ‘ArgR–Mcm1p’ complex (26). When arginine
or ornithine is used as nitrogen source, this complex binds
speciﬁc sequences and activates the catabolic pathway, the
anabolic pathway being simultaneously downregulated. In
the absence of arginine or ornithine, the complex is
formed but does not bind to DNA. Deletion of ARG81
leads to a growth defect on arginine or ornithine and
to constitutive expression of genes encoding anabolic
enzymes (27). In addition, such a mutant strain
appeared to be resistant to canavanine (an arginine
analog) toxicity (28), probably due to the accumulation
of intracellular arginine. It has been shown that a
truncated Arg81p (aa 1–180) can be included in a func-
tionally defective complex (29). The dominant-negative
factor evaluated in this study was then constitutively
overproduced, and was expected to compete with the
endogenous Arg81p for complex formation.
MATERIALS AND METHODS
Strains, culture media and chemicals
Escherichia coli strain XL1blue (Stratagen) was used for
all cloning steps and was cultivated on LB medium. For
selective medium, ampicillin was added at 100mg/ml.
Saccharomyces cerevisiae strains BY4709 (MAT 
ura3D0) (30), 1278b (MAT ) (28), TR2 and TR3 (17)
were used as model strains through the development of
dominant negative marker. DNA of FY1679 (MATa
ura3-52 his3D200/MAT  his3D200 ura3-52) (31) has
served as DNA template for cloning. These S. cerevisiae
strains were cultivated on YPD and on minimum medium
YNB with 80mM ammonium and 20mg/ml glucose
(except for selection media and growth conditions for
transcriptional analysis, see below). 2-Deoxy-D-galactose
was purchased from MP Biomedicals and L-canavanine
from Sigma-Aldrich.
Plasmid construction
All plasmids are described in Table 1. Cloning procedures
are largely described in Supplementary Data.
Transformation, positive and negative selection media
Saccharomyces cerevisiae strains were transformed using
the lithium acetate procedure (32). For 10
8–10
9 harvested
cells concentrated in 100ml, at least 5mg of integrative
vector were added with 5mg of carrier DNA (10mg/ml
ﬁsh sperm DNA solution, MB grade from Roche
Diagnostics GmbH). For basic URA3 selection,
transformants were selected on YNB, 20mg/ml glucose.
For GAL4, the positive selection medium was YNB,
30mg/ml glycerol, 20mg/ml 2-deoxygalatose, 5mg/ml
casaminoacids, 1mg/ml galactose, 200mg/ml glucose, sup-
plemented with 50mg/l leucine or 25mg/ml uracil if
required. For ARG81, the positive selection medium
was YNB, 20mg/ml glucose, 200mg/ml ornithine and
25mg/ml canavanine. Cells were not incubated in a non-
selective growth medium before plating. Geneticin selec-
tion was performed as previously described (5).
The loss of integrative plasmid or deletion cassette was
selected depending on the negative marker. First,
transformants were cultivated overnight at 30 C during
24h on YPD, diluted in fresh media to OD660nm 0.05
and then grown for 24h. Second, 10
4,1 0
6 and 3 10
8
cfu were plated on selective media: YNB, 4mg/ml
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ornithine for ARG81 loss.
PCR characterization
All yeast transformants were characterized by PCR
screening directly with colonies. First, cells were added
to 10ml of 0.25% SDS and heated at 95 C during
15min. After this rapid DNA extraction, 90ml of water
were added and, after 1min of centrifugation at
12000g,1 ml of supernatant was used as DNA template
for PCR. The 25ml-reaction mixture contained 0.4mMo f
each primer, 0.8% Triton X100 and DreamTaq PCR
MasterMix (Fermentas).
Sequencing of PCR fragments carrying genomic HO and
URA3 deletions
Fragments carrying genomic HO and URA3 deletions
were ampliﬁed by PCR with primer pairs ocej359/360
and ocej317/320, respectively (see Supplementary
Table S1 for primer sequences). Fragments were puriﬁed
by using High Pure PCR Product Puriﬁcation Kit (Roche
Diagnostics GmbH) and sequenced using the same
primers (DNAvision S.A.).
Immunodetection by Western blot
After separation by SDS–PAGE, proteins were
electroblotted onto a Hybond nitrocellulose membrane
(GE Healthcare) with XcellII module (Invitrogen) and
with NuPage Transfer Buffer (Invitrogen)/10%
methanol. Tagged proteins were immunodetected with
Anti-V5 antibodies (Invitrogen) and revealed by using
Western-Breeze Chemiluminescent Kit Anti-Mouse
(Invitrogen).
Quantitative qRT–PCR
Quantiﬁcation of mRNA was performed as described pre-
viously (33). For inducing GAL genes expression, yeast
strains were cultivated on YNB with 80mM ammonium,
20mg/ml rafﬁnose until OD660nm 0.5 in which 2mg/ml
galatose were added for a further 1-h growth. The
anabolic and catabolic gene transcripts were quantiﬁed
after growth on YNB with 80mM ammonium, 20mg/ml
glucose in the presence or not of 1mg/ml arginine.
Total RNA was extracted as described previously (34).
Primers ampliﬁed a 167-bp fragment of GAL1 (ocej235,
50-CCGAAAAGTGCCCGAGCATA-30; ocej236, 50-GA
CGGCGCAAAGCATATCAA-30), a 145-bp fragment
of GAL2 (ocej237, 50-TGAATTGAAAGCCGGTGA
GT-30; ocej238, 50-GGTATCCCAGCCAAACATGA-30),
a 169-bp fragment of GAL10 (GAL10-O1, 50-TGGGTTC
CGGTAAAGGTTCT-30; GAL10-O2, 50-TGCAACTCG
GTCTGCCATTT-30), a 149-bp fragment of CAR1
(CAR1-O1, 50-AATACCCCGATGCTGGTCTT-30;
CAR1-O2, 50-TTTGAGCGACTCGGGACAAT-30), a
100-bp fragment of ARG3 (ARG3-O1, 50-GCCCGTGT
GAACAAACATGA-30; ARG3-O2, 50-TTGCTTGCAA
AGGGTGGAAT-30) and a 125-bp fragment of TBP1
(TBP1-O1, 50-TATAACCCCAAGCGTTTTGC-30;
TBP1-O2, 50-GCCAGCTTTGAGTCATCCTC-30).
Confocal imaging
Cells were imaged on LSM510-Axiovert 100M confocal
microscope (Zeiss) by exciting eGFP fusion at 488nm.
RESULTS
Dominant-negative effects resulting from overexpression
of GAL4" or ARG81"
To ensure a constitutive overproduction of truncated
protein, the S. cerevisiae GAL4 sequence coding for
Gal4p (aa 1–147) was placed under the control of the
strong TDH3 promoter. The ORF was fused or not to the
V5 epitope coding sequence allowing immunodetection
with V5-speciﬁc antibodies. The expression cassette was
cloned in integrative vectors. The S. cerevisiae strain
BY4709 was transformed with CYC1 integrative
plasmids (described in Table 1) by conventional URA3
selection. Transformants harboring a single copy of the
empty vector (p0int), plasmid with GAL4 (pGint) or
Table 1. List of plasmids used in this work
Plasmid name Plasmid description
p0int CYC1-integrative plasmid derived from pFL44L with an empty expression cassette (TDH3 promoter and CYC1 terminator).
The restriction by MluI targets integration in genomic CYC1.
pGint p0int carrying GAL4 encoding Gal4p (aa 1–147).
pGVint p0int carrying GAL4DV5 encoding Gal4p (aa 1–147) with C-terminal V5 epitope.
pGVGint p0int carrying GAL4DV5GFP encoding Gal4p (aa 1–147) with C-terminal V5 epitope followed by eGFP.
pAint p0int carrying ARG81 encoding Arg81p (aa 1–180).
pAVint p0int carrying ARG81 encoding Arg81p (aa 1–180) with C-terminal V5 epitope.
pGintL pGint with a 613-bp sequence of LEU2 (from nt 24 to 636). The restriction by KpnI targets integration in genomic LEU2.
pGVintL pGVint with a 613-bp sequence of LEU2. The restriction by KpnI targets integration in genomic LEU2.
pGVdelHO pUC19 carrying the GAL4DV5 expression cassette ﬂanked by two sequences homologous to upstream and downstream of
HO ORF domains, with a short HO direct repeat for vector excision (Figure 4).
pGVdelURA pUC19 carrying the GAL4DV5 expression cassette ﬂanked by two sequences homologous to upstream and downstream of
URA3 ORF, with a short URA3 direct repeat for vector excision (Figure 4).
pGVKdelHO pGVdelHO with KanMX cassette depending on a bidirectional TDH3 promoter (Figure 4).
pGVKdelURA pGVdelURA with KanMX cassette depending on a bidirectional TDH3 promoter (Figure 4).
pAVdelHO pUC19 carrying the ARG81DV5 expression cassette ﬂanked by two sequences homologous to upstream and downstream of
HO ORF domains, with a short HO direct repeat for vector excision (Figure 4).
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after PCR characterization of genomic DNA (data not
shown). The production of the truncated Gal4p was
veriﬁed by immunodetection with V5-speciﬁc antibodies
(Supplementary Figure S1). The phenotypes were
determined by streaking the selected strains on minimal
medium containing either glucose or galactose as sole
carbon source. The growth of strains producing truncated
Gal4p was signiﬁcantly inhibited on galactose, indicating
the occurrence of a dominant-negative effect (Figure 1). It
should be noticed that this phenotype was slightly more
pronounced with the GAL4:V5 construct. This possibly
results from a higher production level of Gal4p-V5
(expression or half-live) or from a functional beneﬁt due
to this particular C-terminal modiﬁcation of the protein
(conformation, interaction with other transcription
factors, etc.). Another plasmid, pGVGint, was constructed
in order to overproduce Gal4p as a fusion with GFP.
The phenotype of a strain carrying such plasmid was
similar to the one observed for pGVint. Observation by
ﬂuorescence microscopy revealed very efﬁcient accumula-
tion of the protein in the nucleus when GAL4 is ex-
pressed under the control of the strong TDH3 promoter
(Figure 2). According to experiments described hereafter,
the dominant-negative effect is due to interference of
GAL4 with the induction of genes belonging to the gal-
actose pathway. Indeed, the transcriptional analysis by
qRT–PCR has shown a signiﬁcant decrease of GAL1,
GAL2 and GAL10 expression in rafﬁnose grown strains
carrying pGint or pGVint plasmids after 1-h pulse with
galactose (Figure 3A). Expression of genes encoding de-
fective transcription factors unrelated to the galactose
pathway did not signiﬁcantly affect expression of GAL
genes (transcriptional analysis of GAL1, GAL2 and
GAL10 in ARG81D:V5 expressing strain, data not
shown) and growth on galactose (see below ARG81).
By a similar approach, the S. cerevisiae ARG81 coding
sequence spreading from ATG to codon 180 (ARG81),
fused or not to the V5 epitope coding sequence, was
placed under the control of TDH3 promoter and cloned
in an integrative plasmid. After transformation of BY4709
strain and selection of transformants harboring a single
copy of these integrative plasmids, the production of
Arg81p was also veriﬁed by immunodetection with
V5-speciﬁc antibodies (data not shown). The phenotype
was veriﬁed by streaking cells on a minimal medium con-
taining ornithine as sole nitrogen source. Growth of
strains expressing ARG81 was inhibited in such
medium (Figure 1), indicating that the production of
truncated Arg81p is sufﬁcient to establish a dominant-
negative effect. The transcriptional analysis by qRT–
PCR demonstrated a lower induction of catabolic CAR1
expression and a reduced repression of anabolic ARG3
expression in ARG81-expressing strain when cells were
grown in the presence of arginine, as compared to the
wild-type strain (Figure 3B). This dominant-negative
effect was also highlighted through enzymatic assays of
the arginase and the ornithine transcarbamylase (data
not shown). We also veriﬁed that production of truncated
Arg81p does not signiﬁcantly affect growth on galactose
and that production of truncated Gal4p does not interfere
with growth on ornithine, conﬁrming the speciﬁcity of the
dominant-negative effects (Figure 1).
Drug resistance due to dominant-negative effect of
GAL4" and ARG81"
Various enzymes are able to convert speciﬁc prodrugs to
toxic compounds and such property has been exploited for
developing negative selection systems using particular
mutant host strains (35,36). Such possibility was offered
for the galactose pathway, and exploited in prototrophic
host strains using GAL4.
Resistance to 2DG, a glycolysis inhibiting prodrug
whose toxic effect is supposed to require a permease (pre-
sumably Gal2p) and the Gal1p galactokinase (24,37), was
evaluated. This required modiﬁcation of the growth
medium, as previous assays involved a wild-type strain
and mutants constitutively expressing the GAL genes.
Various assays were performed to deﬁne a medium
allowing a GAL4 strain to be intoxicated by 2DG while
GAL4-expressing strains being able to grow. A deﬁned
medium was optimized in view of selection of
transformants carrying GAL4 (data not shown). The
optimal medium contains 1mg/ml galactose to induce
the GAL genes (whose expression is required for 2DG
glucose galactose 2DG
p0int
pGint
pGV
int
canavanine
pAVint
pAint
ornithine
Figure 1. Phenotype determination of GAL4 and ARG81 express-
ing S. cerevisiae strains. BY4709-derived strains carrying the various
integrated vectors were streaked on diverse media for identifying
phenotypes. P0int: negative control vector; pGint: GAL4 expression
vector; pGVint: GAL4:V5 expression vector; pAVint: ARG81:V5
expression vector; pAint: ARG81 expression vector. First column:
minimal medium (YNB) with 20mg/ml glucose as carbon source (no
signiﬁcant effect resulting from expression of GAL4 or ARG81).
GAL4-associated phenotypes were observed on YNB with 20mg/ml
galactose (second column) and on 2DG selection medium (YNB with
30mg/ml glycerol, 20mg/ml 2DG, 5mg/ml casaminoacids, 1mg/ml gal-
actose and 0.2mg/ml glucose, third column). ARG81-related pheno-
types were highlighted on YNB with 1mg/ml ornithine as sole nitrogen
source (fourth column) and on canavanine selection medium
(YNB with 80mM ammonium, 20mg/ml glucose, 200mg/ml ornithine
and 8mg/ml canavanine, (ﬁfth column).
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30mg/ml glycerol (carbon sources for transformants
carrying GAL4) and 5mg/ml casaminoacids (improving
growth of transformants carrying GAL4). The deﬁned
glucose concentration is apparently insufﬁcient to impair
the induction of GAL genes expression as well as galactose
and deoxygalactose uptake. A reduced toxicity of this
prodrug could be observed upon expression of GAL4
(Figure 1).
It was previously demonstrated that resistance to
canavanine is encountered in can1 and argR mutants
(38). ARG81-expressing strains were streaked on a selec-
tion medium (YNB, 80mM ammonium, 20mg/ml
glucose, 200mg/ml ornithine, 8mg/ml canavanine) render-
ing evident the canavanine resistance of argR mutants
(38). As compared to the ARG81 control strain,
ARG81-expressing cells were resistant to the drug
(Figure 1). ARG81 was then also potentially usable as
positive selection marker.
Genetic engineering vectors for prototrophic
S. cerevisiae strains
The selection through 2DG-resistance was assayed by
transforming laboratory strains with a classical integrative
plasmid carrying the GAL4:V5 selective marker
(Supplementary Figure S2). After transformation of
1278b (haploid strain) and BY4700/9 (diploid strain),
tiny colonies were obtained after 5–7 days on 2DG
medium, picked with the aid of a binocular and puriﬁed
by streaking on a fresh 2DG selection plate. The small size
of the transformants was probably due to the low glucose
concentration in the 2DG medium (only 0.2mg/ml) and
the residual metabolic activity of non-transformed cells.
More than 50% of diploid colonies harbored the
expected disruption of the targeted allele, as shown by
PCR analysis of genomic DNA (data not shown) and
expected 2:2 leu2:LEU2 segregation was observed after
sporulation. For 1278b,  1% of 2DG-resistant clones
appeared to carry the integrated vector. This lower
efﬁciency probably results from a high frequency of spon-
taneous 2DG-resistant mutants (likely to be recessive,
as not observed with the diploid). PCR-screening of the
colonies should then be needed when transforming
haploid strains. The efﬁciency of the negative selection
system was demonstrated by selecting the vector excision
event. Indeed, after growth on non-selective YPD medium
and plating on minimal medium with galactose as
sole carbon source, colonies showed a GAL4/LEU2
phenotype.
To further evaluate the efﬁciency of the GAL4 selec-
tion marker, gene deletions were performed in wild yeast
strains (‘TR strains’) (17). As most of the S. cerevisiae wild
strains, they are homothallic diploids, which implies that
HO needs to be deleted for generating stable genetically
modiﬁed recombinant strains (otherwise haploids of both
mating types should appear after sporulation, giving rise
spontaneously to a diploid cellular population by mating).
For such purpose, a vector including a GAL4 selective
marker surrounded by upstream and downstream HO se-
quences and an appropriate small 30bp directly repeated
HO sequence for subsequent vector excision was con-
structed (Table 1 and Figure 4). BamHI restriction sites
were created for allowing the generation of appropriate
DNA fragments for gene-replacement by homologous
recombination.
TR3, a GAL and 2DG-sensitive diploid strain, was ﬁrst
chosen for performing genetic modiﬁcations with the
GAL4 system. The pGVdelHO BamHI-digested vector
was introduced into TR3 after transformation and selec-
tion on the 2DG medium. After 5 days, colonies were
picked and puriﬁed by streaking on a fresh selection
plate. PCR-characterization of genomic DNA has shown
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Figure 2. Subcellular localization of truncated Gal4p-V5 fused to GFP.
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cassette integrated in HO locus. After dissecting tetrads,
stable ho haploids deriving from TR3 were obtained (2:2
HO:ho segregation). The integrated cassette in HO locus
was then excised by spontaneous homologous recombin-
ation involving the small directly repeated HO sequences
(Figure 5), by selecting haploid GAL clones after growth
on YPD medium as described in ‘Materials and Methods’
section (PCR characterization, Supplementary Figure S3).
The cassette pop-out frequency was estimated at
3 10
 5±6.5 10
 6 from a set of three independent ex-
periments. The expected accurate deletion of HO was con-
ﬁrmed by PCR-ampliﬁed genomic DNA sequencing.
Among eight analyzed clones deriving from ﬁve
independent transformants, seven carried the expected
deletion (only one revertant showed an unexplained re-
combination event). Haploid strains of each mating type
carrying the desired accurate HO deletion and devoid of
any foreign DNA element were obtained and mated in
order to generate a ho/ho diploid strain, TR3ho.
Afterwards, URA3 deletions were performed in
TR3ho strain to generate modiﬁed hosts that could be
transformed with classical expression vectors. For this
purpose, a vector carrying the GAL4:V5 cassette sur-
rounded by appropriate URA3 sequences was similarly
constructed, pGVdelURA3 (Table 1 and Figure 4).
Using the same approach, the deletion of URA3 was suc-
cessfully carried out starting from the diploid strain with a
transformation efﬁciency of >50%. Haploids of both
mating types carrying expected accurate deletions of
URA3, as conﬁrmed by genomic DNA sequencing, were
obtained. Successive genetic modiﬁcations of strains could
systematically be performed in the same way, by trans-
forming diploids and performing classical genetics.
Indeed, such procedure allows verifying expected segrega-
tion of the genetic modiﬁcations and selecting modiﬁed
haploids of both mating types. In comparison, transform-
ation of TR3ho-derived haploids was undertaken and, as
mentioned above with 1278b, extensive PCR-screening
was required (transformation efﬁciency of 7.8±4.3%),
conﬁrming that the diploid-transformation procedure is
more convenient.
Surprisingly, some TR strains appeared to be naturally
2DG-resistant despite their GAL phenotype. One of these,
the TR2 diploid, was transformed using a construct in
which a neo marker was associated to GAL4 (bidirec-
tional TDH3-driven expression cassette), designed for
the deletion of HO ORF (pGVKdelHO; Table 1 and
Figure 4). After selection of G418-resistant transformants
and PCR characterization, we observed a gal phenotype.
Therefore, the dominant-negative effect of GAL4 does
occur in such 2DG-resistant wild strain. Using haploids
derived from these TR2 transformants, stable ho haploids
devoid of foreign DNA sequences were obtained
after spontaneous vector excision at a frequency of
1.4 10
 4±6 10
 6 (based on three independent
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Figure 3. (A) Transcriptional analysis of GAL1, GAL2 and GAL10
expression in wild-type (carrying empty CYC1 integrative plasmid
p0int) and truncated Gal4p overproducing S. cerevisiae strains (harbor-
ing CYC1 integrative pGint and pGVint vectors, enabling the expres-
sion of GAL4 and GAL4:V5 respectively). Strains were cultivated
on YNB with 20mg/ml rafﬁnose (glucose repression relieved, no gal-
actose induction) and, for inducing GAL gene expression, 2mg/ml gal-
actose was added for one hour. mRNA of GAL1, GAL2 and GAL10
were quantiﬁed by qRT–PCR and the values were normalized with
TBP1 mRNA. (B) Transcriptional analysis of ARG3 and CAR1 expres-
sion in wild-type (carrying empty integrative plasmid p0int) and
truncated Arg81p overproducing S. cerevisiae strains (harboring
CYC1 integrative pAint and pAVint vectors, enabling the expression
of ARG81 and ARG81:V5 respectively). Strains were cultivated
either on YNB with 80mM ammonium, 20mg/ml glucose (expression
of arginine biosynthesis genes, repression of arginine catabolic pathway
genes) or on YNB with 80mM ammonium, 20mg/ml glucose and 1mg/
ml arginine (repression of arginine anabolic pathway genes, induction
of arginine degradation genes). By qRT–PCR, mRNA of ARG3 and
CAR1 were quantiﬁed and the values were normalized with TBP1
mRNA.
tTEF
tTEF
neo
neo
pTDH3
pTDH3
pTDH3
pTDH3 tCYC1
tCYC1
tCYC1 pTDH3
GAL4D:V5
GAL4D:V5
GAL4D:V5
ARG81D:V5
HO up 
HO up 
HO up 
URA3 up
URA3 up
HO down 
HO down
HO down 
URA3 down 
URA3 down
pGV
delHO
pGV
delURA
pGVK
delHO
pGVK
delURA
pAV
delHO
tCYC1 GAL4D:V5
tCYC1
Figure 4. Scheme of integrative cassettes for the deletion of HO and
URA3. All cassettes are excised from pUC19 plasmid by a BamHI
double digest. Up sequences are identical to a sequence upstream of
targeted ORF and down sequences are identical to a sequence down-
stream of targeted ORF. Dashed yellow and blue boxes are small 30
repeats of upstream HO and URA3 sequences, respectively.
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then be convenient for modifying GAL strains that are
not sensitive to 2DG (approach validated in BY4709
strain, data not shown). In addition, this vector provides
an alternative for transformation of prototroph haploids
(speciﬁcally in case only one mating type is available), as it
avoids the PCR-screening of transformant candidates
which was required with the 2DG selection due to the
relatively high frequency of non-transformed
2DG-resistant haploid clones as mentioned above.
We also used the ARG81 marker for modifying
the 2DG-resistant TR2 strain, with an optimized selective
medium with canavanine (25mg/ml). Using BamHI-
digested pAVdelHO (Table 1 and Figure 4), deletion of
HO was successfully carried out (data not shown). After
sporulation, ho haploids of both mating types were
obtained. The growth of these ho haploids on ornithine
as nitrogen source was inhibited, as expected, allowing
selection of vector excision after growth on non-selective
YPD medium, at a frequency of 5.5 10
 5±1.6 10
 5.
The expected accurate deletion of HO gene was conﬁrmed
by PCR-ampliﬁed genomic DNA sequencing. The
ARG81 marker may then provide a useful alternative
for modifying 2DG-resistant strains.
In order to compare efﬁciencies of the 2DG and
canavanine positive selection systems, a series of
transformation experiments were performed with the
HO and URA3 deletion vectors in TR2 and TR3 strains
(Table 2). These results demonstrate that the two selection
systems have similar efﬁciencies. A set of convenient
vectors harboring GAL4 and ARG81 was developed
(see Figure 6 and plasmid sequences in Supplementary
Data). With such plasmids, the introduction of homolo-
gous sequences to loci to be targeted can be easily
carried out via two polylinkers ﬂanking the selection
cassette.
CONCLUSION
The use of dominant-negative truncated transcription
factors designed for interfering with speciﬁc regulatory
pathways has been shown to allow performing precise
genetic modiﬁcation of wild strains of S. cerevisiae. This
method should be convenient for performing any
site-directed modiﬁcation [including point-mutations, as
described in ref. (6)] in the genome, and avoids
side-alterations in the locus, which is useful for a
number of functional studies. The approach is based on
the use of a single expression cassette leading to both re-
sistance to a toxic compound and inhibition of growth on
a speciﬁc substrate. It is particularly attractive for speciﬁc
applications, such as building of genetically modiﬁed
strains for the food industry, as only speciﬁc genes
derived from the host strain should be used (avoiding
the utilization of foreign genes). The described method is
also more powerful than previously described systems
such as 5-ﬂuoroorotic acid resistance of ura3 strains.
targeted ORF
gene deletion by homologous
recombination, prodrug selection
cassette excision by homologous
recombination, counter-selection
Δ transcriptional regulator cassette
Figure 5. Scheme of gene deletion by homologous recombination between linearized integrative vectors and targeted genomic sequences, and
subsequent excision by homologous recombination between the designed short (30bp) directly repeated genomic sequences.
Table 2. Evaluation of transformation efﬁciencies for HO deletion in
TR3 by pGVdelHO (2-deoxygalactose selection), URA3 deletion in
H2n1 (ho/ho diploid derived from TR3) by pGVdelURA (2DG selec-
tion) and HO deletion in TR2 by pAVdelHO (canavanine selection)
Strain Vector/selection Mean transformation
efﬁciency
(total screened
colonies)
Standard
deviation
TR3 pGVdelHO/2DG 63.3% (66) ±4.9%
TR3ho pGVdelURA/2DG 34.0% (79) ±8.7%
TR2 pAVdelHO/canavanine 91.7% (47) ±0.8%
Transformation efﬁciency is deﬁned as the percentage of
PCR-characterized-colonies harboring the deletion cassette at the
expected locus. The amount of screened colonies is given between
brackets. The mean calculation and standard deviation are based on
three independent experiments.
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speciﬁc mutation or deletion. Moreover, in the speciﬁc
case of the Saccharomyces wild strains, a preliminary
deletion of HO is required for generating stable
haploids, and the growth defect resulting from transcrip-
tional interference appeared to be very convenient for sub-
sequent vector recycling.
Resistance to a drug resulting from interference with a
speciﬁc regulatory pathway is apparently not as systemat-
ically observed than metabolic alteration leading to
growth inhibition. Indeed, not all the GAL wild strains
appeared to be sensitive to 2DG in the various growth
conditions assayed (data not shown). However, trans-
formation of the 2DG-resistant diploid TR2 using a neo
marker associated to the GAL4 cassette gave rise to
transformants that were deﬁcient for growth on galactose.
Therefore, the transcriptional interference occurred, and
the counter-selection was adequate for selection of subse-
quent vector excision on the galactose medium. We could
not explain such resistance behavior on 2DG, as the
toxicity of this prodrug through inhibition of glycolysis
is not fully understood (37). Possibly, 2DG is not trans-
ported by the galactopermease or the derivative
compound (2-deoxygalactose-1-phosphate and/or
UDP-2-deoxygalactose) is not efﬁciently produced or
else its toxic effect is not exerted in all GAL strains. In
case of TR2, canavanine appeared to be toxic, and
ARG81 was successfully used as positive/negative selec-
tion marker, which offers an useful alternative to GAL4.
Based on the existing knowledge on metabolic pathways
and regulatory genes, it should be possible to design a
number of alternative dominant-positive/negative selec-
tion systems (see phenotypes database of Saccharomyces
Genome Database). Systematic studies could be designed
which should allow generating both useful knowledge on
known or predicted transcription factors as well as iden-
tifying new selective markers of interest, by searching for
dominant-negative phenotypes upon transformation with
appropriate constructs involving the neo positive marker,
for example.
The approach could be extended to other yeasts, but
also to other microorganisms. Data generated in the
context of genomic sequencing projects allow identifying
an increasing number of candidate genes for generating
such modiﬁed transcription factors. For genetic modiﬁca-
tion of diploid wild strains of Saccharomyces, the use of
modiﬁed transcription factors appeared to be particularly
efﬁcient. In this respect, it should be noticed that diploidy
or polyploidy has been observed in the case of various
wild microorganisms (various lower eukaryotes, but also
bacteria and archaea) (39–41).
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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